Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cells.
about
Gemcitabine-oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed.Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cellsDifferential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines.Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells.Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenografts.
P2860
Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cells.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cells.
@en
type
label
Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cells.
@en
prefLabel
Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cells.
@en
P2093
P1433
P1476
Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cells.
@en
P2093
A Reissigl
F H Geisen
G Konwalinka
M Schirmer
P304
P356
10.1002/(SICI)1097-0045(199603)28:3<172::AID-PROS4>3.0.CO;2-H
P577
1996-03-01T00:00:00Z